BCLC STAGE B HEPATOCELLULAR CARCINOMA
Clinical trials for BCLC STAGE B HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BCLC STAGE B HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for BCLC STAGE B HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo after radiation shows promise for untreatable liver cancer
Disease control OngoingThis early-stage trial tests whether giving two immunotherapy drugs (durvalumab and tremelimumab) after a targeted radiation treatment can help control advanced liver cancer that cannot be removed by surgery. The study involves 25 adults with liver cancer that has spread locally.…
Matched conditions: BCLC STAGE B HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Radioactive beads offer new hope for inoperable liver cancer
Disease control OngoingThis study tests a treatment called selective internal radiation therapy (SIRT) for people with liver cancer that cannot be removed by surgery. Tiny radioactive beads are injected into the liver to deliver radiation directly to tumors. The goal is to shrink the cancer and control…
Matched conditions: BCLC STAGE B HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: Sirtex Medical • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC